Literature DB >> 14697676

LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease.

S M Harrison1, C Reavill, G Brown, J T Brown, J E Cluderay, B Crook, C H Davies, L A Dawson, E Grau, C Heidbreder, P Hemmati, G Hervieu, A Howarth, Z A Hughes, A J Hunter, J Latcham, S Pickering, P Pugh, D C Rogers, C S Shilliam, P R Maycox.   

Abstract

Several psychiatric diseases, including schizophrenia, are thought to have a developmental aetiology, but to date no clear link has been made between psychiatric disease and a specific developmental process. LPA(1) is a G(i)-coupled seven transmembrane receptor with high affinity for lysophosphatidic acid. Although LPA(1) is expressed in several peripheral tissues, in the nervous system it shows relatively restricted temporal expression to neuroepithelia during CNS development and to myelinating glia in the adult. We report the detailed neurological and behavioural analysis of mice homozygous for a targeted deletion at the lpa(1) locus. Our observations reveal a marked deficit in prepulse inhibition, widespread changes in the levels and turnover of the neurotransmitter 5-HT, a brain region-specific alteration in levels of amino acids, and a craniofacial dysmorphism in these mice. We suggest that the loss of LPA(1) receptor generates defects resembling those found in psychiatric disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14697676     DOI: 10.1016/j.mcn.2003.09.001

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  48 in total

1.  Diversity of lysophosphatidic acid receptor-mediated intracellular calcium signaling in early cortical neurogenesis.

Authors:  Adrienne E Dubin; Deron R Herr; Jerold Chun
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

2.  Imaging of CNS myelin by positron-emission tomography.

Authors:  Bruno Stankoff; Yanming Wang; Michel Bottlaender; Marie-Stephane Aigrot; Frederic Dolle; Chunying Wu; Douglas Feinstein; Guo-Feng Huang; Frank Semah; Chester A Mathis; William Klunk; Robert M Gould; Catherine Lubetzki; Bernard Zalc
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 3.  Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

Authors:  Mu-En Lin; Deron R Herr; Jerold Chun
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-04       Impact factor: 3.072

Review 4.  Neuron-astroglial interactions in cell-fate commitment and maturation in the central nervous system.

Authors:  Joice Stipursky; Tânia Cristina Leite de Sampaio E Spohr; Vivian Oliveira Sousa; Flávia Carvalho Alcantara Gomes
Journal:  Neurochem Res       Date:  2012-05-22       Impact factor: 3.996

5.  Regulation of gene expression and subcellular protein distribution in MLO-Y4 osteocytic cells by lysophosphatidic acid: Relevance to dendrite outgrowth.

Authors:  Katrina M Waters; Jon M Jacobs; Marina A Gritsenko; Norman J Karin
Journal:  Bone       Date:  2011-02-26       Impact factor: 4.398

6.  Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1 receptors.

Authors:  Eduardo Blanco; Ainhoa Bilbao; María Jesús Luque-Rojas; Ana Palomino; Francisco J Bermúdez-Silva; Juan Suárez; Luis J Santín; Guillermo Estivill-Torrús; Antonia Gutiérrez; José Angel Campos-Sandoval; Francisco J Alonso-Carrión; Javier Márquez; Fernando Rodríguez de Fonseca
Journal:  Psychopharmacology (Berl)       Date:  2011-09-02       Impact factor: 4.530

7.  Exploratory, anxiety and spatial memory impairments are dissociated in mice lacking the LPA1 receptor.

Authors:  Estela Castilla-Ortega; Jorge Sánchez-López; Carolina Hoyo-Becerra; Elisa Matas-Rico; Emma Zambrana-Infantes; Jerold Chun; Fernando Rodríguez De Fonseca; Carmen Pedraza; Guillermo Estivill-Torrús; Luis J Santin
Journal:  Neurobiol Learn Mem       Date:  2010-04-11       Impact factor: 2.877

8.  Rapid and reversible enhancement of blood-brain barrier permeability using lysophosphatidic acid.

Authors:  Ngoc H On; Sanjot Savant; Myron Toews; Donald W Miller
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-18       Impact factor: 6.200

Review 9.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

Review 10.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.